Steven Madden

SHOO · NASDAQ

$45.06+$0.10 (+0.22%)TodayMarket closed ·
Prev close $44.96

SHOO analyst rating

BuyConsensus of 7 analysts over the last 12 months. 86% rate it a buy.
  • Strong buy0
  • Buy6
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 13 analysts

Average $52.86 (+17.3% upside)

Low
$36.36
Now
$45.06
High
$63.00

Upgrades and downgrades

The latest rating actions, newest first

SHOO analyst upgrades, downgrades and rating actions
FirmDateActionRating
BMO CapitalSep 9, 2026InitiatesOutperform
Piper SandlerAug 5, 2026MaintainsOverweight
UBSJul 31, 2026MaintainsNeutral
CitigroupJul 31, 2026MaintainsBuy
BTIGJul 30, 2026MaintainsBuy
BTIGJul 27, 2026MaintainsBuy
NeedhamJun 12, 2026MaintainsBuy
BTIGJun 4, 2026MaintainsBuy
NeedhamMay 6, 2026MaintainsBuy
NeedhamMay 4, 2026MaintainsBuy

The case for and against

Updated Oct 14, 2026

Bull case

Steven Madden is positioned for a constructive fundamental rebound as fashion footwear demand shifts toward dressier styles, broadening across flats, heels, boots, and Mary Janes rather than depending on a single trend. Wholesale appears to be recovering after a tough 2025, with last year’s 9% organic decline likely to partially reverse as tariffs and inventory disruptions ease, private label stabilizes, and handbags are expected to return to growth in Q2. The company also has a meaningful margin recovery path, with EBIT margin falling more than 400 bps last year to about 7% and supported going forward by higher pricing, product mix, reduced promotions, and the accretive Kurt Geiger acquisition.

Bear case

Steven Madden is exposed to weakening demand and channel caution, as declining U.S. consumer confidence and tighter inventory management by wholesale partners could pressure revenue and reduce sell-in. Wholesale already showed clear softness, with organic sales down 8%, including footwear down 12% and apparel/accessories down 1%, while private label is expected to fall more than 20% in FY26, extending margin and growth headwinds. Tariff pressure adds another layer of risk because if mitigation falls short, EPS could drop to $1.75 next year, underscoring the stock’s vulnerable fundamentals.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.